Structural basis for the structure-activity relationships of peroxisome proliferator-activated receptor agonists
Mahindroo, N., Peng, Y.H., Lin, C.H., Tan, U.K., Prakash, E., Lien, T.W., Lu, I.L., Lee, H.J., Hsu, J.T.A., Chen, X., Liao, C.C., Lyu, P.C., Chao, Y.S., Wu, S.Y., Hsieh, H.P.(2006) J Med Chem 49: 6421-6424
- PubMed: 17034149 
- DOI: https://doi.org/10.1021/jm060663c
- Primary Citation of Related Structures:  
2HWQ, 2HWR - PubMed Abstract: 
Type 2 diabetes has rapidly reached an epidemic proportion becoming a major threat to global public health. PPAR agonists have emerged as a leading class of oral antidiabetic drugs. We report a structure biology analysis of novel indole-based PPAR agonists to explain the structure-activity relationships and present a critical analysis of reasons for change in selectivity with change in the orientation of the same scaffolds. The results would be helpful in designing novel PPAR agonists.
Organizational Affiliation: 
Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, 35 Keyan Road, Zhunan Town, Miaoli County 350, Taiwan, Republic of China.